|
Generic Name : Carfilzomib
Trade Name(s): International- Kyprolis. Why it is prescribed (Indications) : This medication is an antineoplastic agent, prescribed for multiple myeloma. It helps to slow the growth and spread of the cancer. When it is not to be taken (Contraindications): None.
Dosage & When it is to be taken : IV- Cycle 1- The recommended dose is 20 mg/m². If tolerated in Cycle 1, the dose should be increased to 27 mg/m² beginning in Cycle 2 and continued at 27 mg/m² in subsequent cycles. How it should be taken : It comes as a powder for injection (diluted with fluid) to be administered by a healthcare provider into the vein. Warnings and Precautions : * Caution should be exercised in patients with history of heart arrest, congestive heart failure, high blood pressure, any allergy, who are taking other medications, during pregnancy and breastfeeding. * It may cause fatigue, dizziness, fainting, and/or low blood pressure, do not drive a car or operate machinery while taking this medication. * Patient may experience shortness of breath, if it is so consult with your healthcare provider. Side Effects : Fatigue, anemia, nausea, decrease in platelets, difficulty in breathing, diarrhea, and fever. * Avoid excess dosage. Storage Conditions : Store it in refrigerator (2°C to 8°C). |
![]() Comment & Contribute
![]()
![]() ![]() | ||



Ask an Expert